This inventor holds 2 USPTO granted patents. Top assignee: G1 Therapeutics, Inc.. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Innovations by Hua Zhong in the Field of Pyrimidine-Based Compounds
Introduction
Hua Zhong is an accomplished inventor based in Boston, MA, known for his significant contributions to the field of medicinal chemistry. He holds two patents that focus on the synthesis of pyrimidine-based compounds, which are crucial in the treatment of various disorders, including tumors and cancers.
Latest Patents
Hua Zhong's latest patents include the synthesis of N-(heteroaryl)-pyrrolo[3,2-d]pyrimidin-2-amines. This invention is aimed at creating compounds that can be utilized in treating disorders characterized by abnormal cellular proliferation. The compounds developed through this synthesis have potential applications in oncology, particularly for tumors and cancers.
Career Highlights
Hua Zhong is currently associated with G1 Therapeutics, Inc., where he continues to innovate and develop new therapeutic solutions. His work is pivotal in advancing the understanding and treatment of cancer-related disorders through chemical synthesis.
Collaborations
Throughout his career, Hua Zhong has collaborated with notable colleagues, including Alexander Smith and Hannah S. White. These collaborations have fostered a productive environment for research and development, enhancing the impact of their collective work in the field.
Conclusion
Hua Zhong's contributions to the synthesis of pyrimidine-based compounds represent a significant advancement in medicinal chemistry. His patents and ongoing work
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile